Ján Koreň, Michal Koreň
Nowadays nosocomial infections become increasingly apparent and media present them like dangerous even fatal infections, which can be acquired in the healthcare facilities. Clostridium difficile (C. difficile) is approximately in one-third hospitalized patients’ carrier strain(1). This anaerobe spore-forming bacterium remains in patients even during specific therapy and in the vegetative form it produces toxin A and B. Spores are resistant to the most of disinfectants in the hospital setting. These are the reasons for frequent relapses or re-infections as repeated diarrhea and other symptoms after the primo infection treatment. A case report of the first patient with polymorbidity points on relapse associated with C. difficile toxin A by six hospitalization can lead, as one of other risk factors, to the lethal end. In the second elderly female patient the disease was in due time diagnosed. Specific effective therapy was accordingly prescribed and she was discharged in good condition to the ambulatory care. We emphasize the importance of prevention, respect of hygienic - epidemiological regime, barrier technique, rational antibiotics indication, timely proof in desirable stool examination of C. difficile toxin A and overpass on a specific effective therapy - metronidazole, vancomycin. Similarly, relapse prevention is important in risk patients.